Cargando…

Association of time‐to‐intravenous furosemide with mortality in acute heart failure: data from REPORT‐HF

AIM: Acute heart failure can be a life‐threatening medical condition. Delaying administration of intravenous furosemide (time‐to‐diuretics) has been postulated to increase mortality, but prior reports have been inconclusive. We aimed to evaluate the association between time‐to‐diuretics and mortalit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ouwerkerk, Wouter, Tromp, Jasper, Cleland, John G.F., Angermann, Christiane E., Dahlstrom, Ulf, Ertl, Georg, Hassanein, Mahmoud, Perrone, Sergio V., Ghadanfar, Mathieu, Schweizer, Anja, Obergfell, Achim, Dickstein, Kenneth, Filippatos, Gerasimos, Collins, Sean P., Lam, Carolyn S.P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd. 2022
Materias:	Acute Heart Failure
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099670/ https://www.ncbi.nlm.nih.gov/pubmed/36196060 http://dx.doi.org/10.1002/ejhf.2708

Ejemplares similares

Hospitalization for acute heart failure during non‐working hours impacts on long‐term mortality: the REPORT‐HF registry
por: Katsanos, Spyridon, et al.
Publicado: (2023)

Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction
por: van Essen, Bart J., et al.
Publicado: (2022)

International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT‐HF): rationale for and design of a global registry
por: Filippatos, Gerasimos, et al.
Publicado: (2015)

Continuous infusion of furosemide versus intermittent boluses in acute decompensated heart failure: Effect on thoracic fluid content
por: Ragab, Dalia, et al.
Publicado: (2018)

Morphine in the Setting of Acute Heart Failure: Do the Risks Outweigh the Benefits?
por: Caspi, Oren, et al.
Publicado: (2020)

Temporary Mechanical Circulatory Support in Acute Heart Failure
por: Jiritano, Federica, et al.
Publicado: (2020)

Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure
por: Boorsma, Eva M., et al.
Publicado: (2020)

SOLOIST‐WHF and updated meta‐analysis: sodium–glucose co‐transporter 2 inhibitors should be initiated in patients hospitalized with worsening heart failure
por: Docherty, Kieran F., et al.
Publicado: (2020)

Cardiac output improvement by pecavaptan: a novel dual‐acting vasopressin V1a/V2 receptor antagonist in experimental heart failure
por: Mondritzki, Thomas, et al.
Publicado: (2020)

Referral for Specialist Follow-up and Its Association With Post-discharge Mortality Among Patients With Systolic Heart Failure (from the National Heart Failure Audit for England and Wales)
por: Emdin, Connor A., et al.
Publicado: (2017)

Characterisation of circulating biomarkers before and after cardiac resynchronisation therapy and their role in predicting CRT response: the COVERT-HF study
por: McAloon, Christopher J, et al.
Publicado: (2018)

Rationale and design of the preserved versus reduced ejection fraction biomarker registry and precision medicine database for ambulatory patients with heart failure (PREFER-HF) study
por: Abboud, Andrew, et al.
Publicado: (2021)

Kolkata-Coventry comparative registry study of acute heart failure: an insight into the impact of public, private and universal health systems on patient outcomes in low–middle income cities (KOLCOV HF Study)
por: Banerjee, Suvro, et al.
Publicado: (2022)

Prevalence and prognostic impact of kidney disease on heart failure patients
por: Löfman, Ida, et al.
Publicado: (2016)

Prevalence of left ventricular dysfunction in a UK community sample of very old people: the Newcastle 85+ study
por: Yousaf, Fahad, et al.
Publicado: (2012)

Effect of Left Ventricular Assist Device Implantation and Heart Transplantation on Habitual Physical Activity and Quality of Life()
por: Jakovljevic, Djordje G., et al.
Publicado: (2014)

The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective
por: Griffiths, A, et al.
Publicado: (2014)

Obesity paradox in heart failure patients – Female gender characteristics-KAMC-single center experience
por: Khaled, Sheeren, et al.
Publicado: (2017)

Clinical and laboratory characteristics of short-term mortality in Egyptian patients with acute heart failure
por: Abdellah, Ahmad Tageldien, et al.
Publicado: (2017)

Effect of cardiac rehabilitation on cardiovascular risk factors in chronic heart failure patients
por: Mohammed, Haitham Galal, et al.
Publicado: (2018)

Myocardial performance index as an echocardiographic predictor of early in-hospital heart failure during first acute anterior ST-elevation myocardial infarction
por: Abuomara, Hossamaldin Zaki Alsayed, et al.
Publicado: (2018)

Assessment of right ventricular function by echocardiography in patients with chronic heart failure
por: William, Viola, et al.
Publicado: (2018)

Prevalence of P wave dispersion and interatrial block in patients with systolic heart failure and their relationship with functional status, hospitalization and one year mortality
por: Abdellah, Ahmed Tageldien, et al.
Publicado: (2018)

Destination Therapy with Left Ventricular Assist Devices in Non-transplant Centres: The Time is Right
por: Bayes-Genis, Antoni, et al.
Publicado: (2020)

Interatrial Shunting for Treating Acute and Chronic Left Heart Failure
por: Guimaraes, Leonardo, et al.
Publicado: (2020)

Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure
por: Patel, Vaibhav B., et al.
Publicado: (2012)

Arrhythmogenic Cardiomyopathy: A Disease or Merely a Phenotype?
por: Protonotarios, Alexandros, et al.
Publicado: (2020)

Heart Failure Treatment by Device
por: Bayés-Genis, Antoni
Publicado: (2020)

Asymptomatic Left Ventricle Systolic Dysfunction
por: Sara, Jaskanwal D, et al.
Publicado: (2020)

Contemporary Management of Secondary Mitral Regurgitation
por: Goel, Kashish, et al.
Publicado: (2020)

Novel Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease: What Cardiologists and Diabetologists Should Know
por: Martínez, Felipe
Publicado: (2021)

Levosimendan in Europe and China: An Appraisal of Evidence and Context
por: Kong, Xiangqing, et al.
Publicado: (2021)

A Tale of 2 Aneurysms: Cardiogenic Shock Secondary to Vascular Behçet’s Syndrome
por: Doumouras, Barbara S., et al.
Publicado: (2021)

An Uncommon Cause of Dyspnea: Usefulness of Multimodality Cardiac Imaging
por: Pueyo Balsells, Nuria, et al.
Publicado: (2021)

Refractory Recurrent Pericarditis After Pericardiectomy in a Young Woman
por: Lak, Hassan Mehmood, et al.
Publicado: (2021)

Severe Hypoxemia Caused by High-Output Heart Failure and Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia
por: Yamamoto, Hiroaki, et al.
Publicado: (2021)

Heart Failure in a Child: Multimodality Approach Leading to an Unusual Cause
por: Karuru, Uma Devi, et al.
Publicado: (2021)

Efficacy of Ranolazine to Improve Diastolic Performance in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-analysis
por: Putri, Desak Ketut Sekar Cempaka, et al.
Publicado: (2023)

Preoperative Levosimendan therapy reduces postoperative right ventricular failure in patients undergoing left ventricular assist device implantation
por: Sugimura, Yukiharu, et al.
Publicado: (2023)

Associations of short‐ and long‐term mortality with admission blood pressure in Chinese patients with different heart failure subtypes
por: Chen, Shilan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_23h67ut4tc7c9lopp3u4a97smf